BioNTech to Present at the 38th Annual J.P. Morgan Healthcare Conference


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


MAINZ, Germany, Dec. 18, 2019 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ:BNTX) today announced that CEO and Co-founder Ugur Sahin, MD, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020, at 7.30 am PST at the Westin St. Francis Hotel, San Francisco.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A live webcast of the presentation will be available via the "Events & Presentations" page in the Investor Relations section on the Company's website at https://biontech.de/. The replay of the webcast will be archived on the Company's website for 30 days following the conference.

About BioNTech

BioNTech was founded in 2008 on the understanding that every cancer patient's tumor is unique and therefore each patient's treatment should be individualized. Its cutting-edge pipeline includes individualized mRNA-based product candidates, innovative chimeric antigen receptor T cells, novel checkpoint immunomodulators, targeted cancer antibodies and small molecules. BioNTech has established relationships with seven pharmaceutical collaborators, including Eli Lilly and Company, Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Genevant and Pfizer, and has published over 150 peer-reviewed publications on its scientific approach.

For more information, please contact:


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


BioNTech SE                                                                

Michael Boehler, MD, Head of Global External Communications
Tel: +49 (0)6131 9084 1640
Email: Media@biontech.de

Sylke Maas, PhD, Vice President Investor Relations & Business Strategy
Tel: +49 (0)6131 9084 1074
Email: Investors@biontech.de

For all media inquiries:

Trophic Communications
Gretchen Schweitzer / Stephanie May, PhD
Tel: +49 (0)89 23 88 77 30 or +49 (0)171 185 56 82
Email: May@trophic.eu


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: NewsPress Releases